<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Pharmacology - NEET PG 2022</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Pharmacology - NEET PG 2022</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                18 Questions | 18 Total Marks | 28 min Duration | ~93.33 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 18 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 28 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 18</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Pharmacology - NEET PG 2022 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 18</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 18 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 14 years old girl was given intravenous botulinum toxin after which she died. Which of the following is the correct mechanism of action of this toxin ?", "options": [{"label": "A", "text": "Inhibition of Ach Release", "correct": true}, {"label": "B", "text": "Inhibits re-uptake of Nor-Epinephrine", "correct": false}, {"label": "C", "text": "Blockade of Post Synaptic Nicotinic Cholinergic Receptors", "correct": false}, {"label": "D", "text": "Inhibit pre synaptic uptake of Ach", "correct": false}], "correct_answer": "A. Inhibition of Ach Release", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Inhibition of Ach Release IV administration of botulinum toxin acts at the neuromuscular junction to cause muscle paralysis by inhibiting the release of acetylcholine from presynaptic motor neurons.</p>\n<p><strong>Highyeild:</strong></p><p>Botulinum toxins act at four different sites in the body: The neuromuscular junction, Autonomic ganglia, Postganglionic parasympathetic nerve endings and Postganglionic sympathetic nerve endings that release acetylcholine. The affected nerve terminals do not degenerate, but the blockage of neurotransmitter release is irreversible. It inhibits the ACh transporter by binding to a site on the inner vesicular membrane surface and is another marker for cholinergic neurons. Vesamicol may have applications for the treatment of adenocarcinoma in situ of the lung.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B: is the mechanism seen with cocaine & derivatives as well as TCAs like Amitriptyline or Imipramine. Option C: Blockade of post synaptic nicotinic cholinergic receptors is seen with neuromuscular blocking drugs (N M blockers) like Atracurium or Rocuronium. Option D: Drugs like Vesamicol act presynaptically by inhibiting acetylcholine (ACh) uptake into synaptic vesicles and reducing its release.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is the drug of choice in acetaminophen overdose?", "options": [{"label": "A", "text": "N- Acetyl Cysteine", "correct": true}, {"label": "B", "text": "Carnitine", "correct": false}, {"label": "C", "text": "Flumazenil", "correct": false}, {"label": "D", "text": "Fomepizole", "correct": false}], "correct_answer": "A. N- Acetyl Cysteine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>N- Acetyl Cysteine The oral formulation of NAC is the drug of choice for the treatment of acetaminophen overdose.</p>\n<p><strong>Highyeild:</strong></p><p>Metabolism of this drug primarily occurs through glucuronidation and sulfuration, both of which occur in the liver. In an overdose, these pathways are saturated, and more acetaminophen is subsequently metabolized to NAPQI by cytochrome P450. NAPQI is a toxic substance that is safely reduced by glutathione to nontoxic mercaptate and cysteine compounds, which are then renally excreted. An overdose depletes the stores of glutathione, and once they reach less than 30% of normal, NAPQI levels increase and subsequently binds to hepatic macromolecules causing hepatic necrosis. This is irreversible. NAC is nearly 100% hepatoprotective when it is given within 8 hours after an acute acetaminophen ingestion. It prevents the binding of NAPQI to hepatic macromolecules, acts as a substitute for glutathione, is a precursor for sulfate, and reduces NAPQI back to acetaminophen. Indications for NAC include: Serum levels that fall in the toxic range according to the Rumack-Matthew nomogram, An APAP level greater than 10 mcg/mL with an unknown time of ingestion, A dose of acetaminophen greater than 140 mg/kg taken more than 8 hours ago, Abnormal labs with ingestion more than 24 hours ago, and Ingestion with any evidence of liver injury. In addition to antidote therapy, supportive care is essential in acetaminophen toxicity. Administer activated charcoal (AC) if the patient has a stable mental and clinical status, patent airway, and presents to the emergency department within 1 hour of ingestion.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B: Carnitine - used to treat valproate hyperammonemia. Option C: Flumazenil ‚Äì antidote for benzodiazepine toxicity. Option D: Fomepizole- methanol & ethylene glycol poisoning.</p>\n<p><strong>Table:</strong></p><p>#MANTRA N-ACETYL CYSTEINE Cheap, Safe Anti oxidant. Has mucolytic, anti-inflammatory, antioxidant and immunomodulatory effects and hence used in: Paracetamol toxicity Renal protection Interstitial lung disease COPD Antioxidant property is made use in the treatment of AIP poisoning</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A young female with throbbing left sided headache associated with nausea and vomiting, photophobia and phonophobia. Which of the following drug can provide immediate relief to this patient?", "options": [{"label": "A", "text": "Propranolol", "correct": false}, {"label": "B", "text": "Sumatriptan", "correct": true}, {"label": "C", "text": "Topiramate", "correct": false}, {"label": "D", "text": "Flunarizine", "correct": false}], "correct_answer": "B. Sumatriptan", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Sumatriptan Given is a typical case scenario of acute migraine episode. Such episodes should be managed with synthetic serotonin receptor agonists like sumatriptan or almotriptan. Their action is attributed to their agonist effects on serotonin 5-HT 1B and 5-HT 1D receptors in blood vessels (causing their constriction) and nerve endings in the brain, and subsequent inhibition of pro-inflammatory neuropeptide release, including CGRP and substance P. It is also used in occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A: Propranolol can be used on a routine basis along with calcium channel blockers (CCBs can also be used alone in prophylaxis of sensitive individuals); but it does not have much use during an acute episode as is described in this scenario. Option C: Topiramate is a carbonic anhydrase inhibitor used alone or with other medications to treat certain types of seizures including primary generalized tonic-clonic seizures and partial onset seizures; especially in patients with concomitant bipolar disorders due to its mood stabilizing properties. It can also be used for prophylaxis of migraines in susceptible individuals. Option D: Flunarizine is a ‚ÄúT‚Äù calcium channel blocker and can be used in routine prophylaxis of migraine in patients where Propranolol isn‚Äôt effective.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following drugs inhibits PCSK-9?", "options": [{"label": "A", "text": "Atorvastatin", "correct": false}, {"label": "B", "text": "Evolocumab", "correct": true}, {"label": "C", "text": "Ezetimibe", "correct": false}, {"label": "D", "text": "Lomitapide", "correct": false}], "correct_answer": "B. Evolocumab", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Evolocumab</p>\n<p><strong>Highyeild:</strong></p><p>They are monoclonal antibodies that bind to pro-protein convertase subtilisin/kexin type 9 (PCSK9) PCSK9 destroys LDL-receptor on hepatocytes, which results in decreases clearance of LDL Inhibition of PCSK9 improves clearance of LDL Toxicity: Myopathy Neurocognitive effects Delirium Dementia</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A - HMG-CoA reductase inhibitors (pravastatin, simvastatin, rosuvastatin) PCSK-9 inhibitors (alirocumab and evolocumab) Acts peripherally Fibrates (gemfibrozil, benzafibrate, and fenofibrate) Niacin Acts on intestinal absorption Bile acid resins (cholestyramine, colestipol, and colesevelam) Option C - Ezetimibe (inhibits sterol transporter at the small intestine brush border, preventing the absorption of cholesterol) Lomitapide (option D) is a microsomal triglyceride transfer protein inhibitor used to lower cholesterol associated with homozygous familial hypercholesterolemia (HoFH), reducing risk of cardiovascular events such as myocardial infarction and stroke. It  binds instantly to and suppresses microsomal triglyceride transfer protein (MTP) inside the endoplasmic reticulum lumen. Suppressing MTP hinders producing lipoproteins that contain apo-B in the hepatocytes and the enterocytes and leads to a decrease in generating very-low-density lipoprotein (VLDL) and chylomicrons and hence decreases the levels of LDL-C in plasma</p>\n<p><strong>Table:</strong></p><p>#MANTRA Relative Effects of Lipid-Lowering Agents on LDL, HDL, and TG Drug LDL HDL TG HMG-CoA reductase inhibitors ‚Üì‚Üì‚Üì* ‚Üë ‚Üì PCSK9 inhibitors ‚Üì‚Üì‚Üì ‚Üë ‚Üì Fibrates ‚Üì ‚Üë ‚Üì‚Üì‚Üì* Niacin ‚Üì‚Üì ‚Üë‚Üë* ‚Üì Bile acid resins ‚Üì‚Üì ‚Üë ‚Üë Ezetimibe ‚Üì ‚Üë/- ‚Üì/-</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A deep vein thrombosis patient was started on an anticoagulant therapy. Next day, the patient presented with the features shown in the image below. What is the likely drug implicated with this adverse effect?", "options": [{"label": "A", "text": "Heparin", "correct": false}, {"label": "B", "text": "Warfarin", "correct": true}, {"label": "C", "text": "Rivaroxaban", "correct": false}, {"label": "D", "text": "Dabigatran", "correct": false}], "correct_answer": "B. Warfarin", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1692796477549-QTDJPYQ050IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Warfarin</p>\n<p><strong>Highyeild:</strong></p><p>Skin necrosis (Dermal necrosis) from warfarin is an uncommon but serious condition, occurring in 1:10,000 patients who receive the drug, with a female: male ratio of 1:4. Obesity, perimenopausal age, viral infections, hepatic disease, and drug interactions are other predisposing factors. Deficiency of protein C, protein S or Factor V Leiden, antithrombin III, hyperhomocysteinemia, and antiphospholipid antibodies are common underlying risk factors. Warfarinization with large loading doses or without initial concomitant heparinization, are common clues in the clinical history, as in the patient presented herein. Pathophysiology: Warfarin inactivates vitamin K-dependent clotting factors II, VII, IX, and X. At the same time, vitamin K-dependent proteins C and S are inactivated. This may cause a paradoxical hypercoagulable milieu in which microthrombi develop in cutaneous and subcutaneous venules, as the concentration of anticoagulant protein C falls more rapidly than other vitamin K-dependent precoagulant factors, which have longer half-lives.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A: Heparin ‚Äì mainly causes bleeding, antidote of heparin toxicity is protamine sulphate. Side effect- alopecia, heparin induced thrombombopenia & osteoporosis. Option C & D: Rivaroxaban and Dabigatran- are novel oral anticoagulant (NOACs). Dabigatran is direct Thrombin Inhibitor. Other drugs mentioned in the rest of the options do not contribute to such scenario.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient with COPD was given intravenous aminophylline therapy following which the patient developed diuresis. This is due to action on which receptors?", "options": [{"label": "A", "text": "Beta 2 Adrenergic Receptors", "correct": false}, {"label": "B", "text": "Adenosine Receptors", "correct": true}, {"label": "C", "text": "IL -10", "correct": false}, {"label": "D", "text": "Histone Deacetylase", "correct": false}], "correct_answer": "B. Adenosine Receptors", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Adenosine Receptors</p>\n<p><strong>Highyeild:</strong></p><p>Aminophylline is an adenosine receptor antagonist that inhibits NaCl reabsorption in the proximal tubule and diluting segments and causes a modest increase in GFR thus leading to diuresis. It is a complex of theophylline and ethylenediamine and is given for its theophylline activity to relax smooth muscle and to relieve bronchial spasm.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Beta 2 adrenergic receptors Drugs like SABAs and LABAs act on these receptors. Their onset of action and duration determines the classification of beta-2 agonists. SABAs are the first-line medications for acute treatment in asthma symptoms and exacerbations. They are also commonly used in conjunction with LABAs, inhaled corticosteroids, or long-acting muscarinic agonists in treatment for COPD. Option C: IL -10 Interleukin-10 (IL-10) is a regulatory cytokine which inhibits both antigen presentation and subsequent pro-inflammatory cytokine release, and it is proposed as a potent anti-inflammatory biological therapy in chronic IBD and rheumatoid arthritis. Also note: Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin